Copolymer-templated nitrogen-doped carbon (CTNC) films deposited on glassy carbon were used as electrodes to study electrochemically driven hydrogen evolution reaction (HER) in 0.5 M H2SO4. The activity of these materials was extremely enhanced when a platinum counter electrode was used instead of a graphite rod and reached the level of commercial Pt/C electrodes. Postreaction scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) measurements of electrode surfaces revealed that incorporation of even extremely low amounts of Pt resulted in this considerable gain of HER activity. High resolution XPS analysis and density functional theory (DFT) calculations confirmed that pyridinic nitrogen atoms act as active sites for Pt coordination and deposition. The Pt can be incorporated in both molecular (Pt(2+)) and metallic (Pt(0)) form. This study shows that great caution must be taken when designing "metal-free" HER catalysts based on N-doped carbons.
Controlling the sequence of repeat units in a synthetic polymer has been a long-standing topic of interest in chemistry. As methods to regulate sequence become more sophisticated, it is critical to consider how controlling the arrangement of repeat units along the polymer backbone impacts properties. In this work, thiophene−selenophene copolymers (statistical and periodic) were compared to elucidate the impact of periodicity on electronic properties and structural organization in conjugated macromolecules. Polymers were synthesized using catalyst-transfer polycondensation (CTP) enabling control over molecular weight and dispersity. The study revealed that optical bandgaps and redox potentials of periodic and statistical copolymers varied with composition in a predictable manner, regardless of monomer ordering along the chain. While the bandgaps of the two types of copolymers were indistinguishable, X-ray scattering revealed differences in solid-state packing. Both types of copolymers exhibited well-defined morphologies, but larger π-stacking distances and more orientational disorder were evident in the statistical systems. This indicates periodicity is an attribute that should be considered when synthesizing semiconducting materials.
Poor water solubility is one of the major challenges to the development of oral dosage forms containing active pharmaceutical ingredients (APIs). Polymorphism in APIs leads to crystals with different surface wettabilities and free energies, which can lead to different dissolution properties. Crystal size and habit further contribute to this variability. An important focus in pharmaceutical research has been on controlling the drug form to improve the solubility and thus bioavailability of APIs. In this regard, heterogeneous crystallization on surfaces and crystallization under confinement have become prominent forms of controlling polymorphism and drug crystal size and habits; however there has not been a thorough review into the emerging field of combining these approaches to control crystallization. This tutorial-style review addresses the major advances that have been made in controlling API forms using combined crystallization methods. By designing templates that not only control the surface functionality but also enable confinement of particles within a porous structure, these combined systems have the potential to provide better control over drug polymorph formation and crystal size and habit. This review further provides a perspective on the future of using a combined crystallization approach and suggests that combining surface templating with confinement provides the advantage of both techniques to rationally design systems for API nucleation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.